标题
Kinase inhibitors: the road ahead
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 5, Pages 353-377
出版商
Springer Nature
发表日期
2018-03-16
DOI
10.1038/nrd.2018.21
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition
- (2018) Samuel E. Dalton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
- (2017) Andrew B. West EXPERIMENTAL NEUROLOGY
- EGFR TKI combination with immunotherapy in non-small cell lung cancer
- (2017) Myung-Ju Ahn et al. Expert Opinion On Drug Safety
- Targeting LRRK2 in Parkinson’s disease: an update on recent developments
- (2017) Sharon L. Chan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- 3D-e-Chem-VM: Structural Cheminformatics Research Infrastructure in a Freely Available Virtual Machine
- (2017) Ross McGuire et al. Journal of Chemical Information and Modeling
- Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design
- (2017) Katherine L. Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
- (2017) Andrew P. Crew et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
- (2017) Kwok-Ho Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
- (2017) Jack D. Scott et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
- (2017) Mary E. Matyskiela et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protein Degradation via CRL4CRBN Ubiquitin Ligase: Discovery and Structure–Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1
- (2017) Joshua D. Hansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors
- (2017) Martin Golkowski et al. JOURNAL OF PROTEOME RESEARCH
- Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations
- (2017) Matteo Aldeghi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
- (2017) Qian Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Global survey of the immunomodulatory potential of common drugs
- (2017) Gregory I Vladimer et al. Nature Chemical Biology
- Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells
- (2017) Liv Johannessen et al. Nature Chemical Biology
- Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
- (2017) Calla M Olson et al. Nature Chemical Biology
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- Non-kinase targets of protein kinase inhibitors
- (2017) Lenka Munoz NATURE REVIEWS DRUG DISCOVERY
- Molecular neurobiology of mTOR
- (2017) Katarzyna Switon et al. NEUROSCIENCE
- Redox-based reagents for chemoselective methionine bioconjugation
- (2017) Shixian Lin et al. SCIENCE
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions
- (2017) Tiansheng Wang et al. ACS Medicinal Chemistry Letters
- Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
- (2017) Klemens Hoegenauer et al. ACS Medicinal Chemistry Letters
- Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult
- (2017) Martin Larhammar et al. eLife
- Progress towards a public chemogenomic set for protein kinases and a call for contributions
- (2017) David H. Drewry et al. PLoS One
- Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model
- (2017) Hong Wu et al. Scientific Reports
- Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors
- (2016) Susan Klaeger et al. ACS Chemical Biology
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cancer Immunology and Immunotherapy
- (2016) AMMAR SUKARI et al. ANTICANCER RESEARCH
- Computational methods in drug discovery
- (2016) Sumudu P Leelananda et al. Beilstein Journal of Organic Chemistry
- Abstract 3025: Discovery of preclinical development candidate inhibitors of the mediator complex-associated kinases CDK8 and CDK19 and evaluation of their therapeutic potential
- (2016) Paul Clarke et al. CANCER RESEARCH
- Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer
- (2016) Maria Teresa Herrera-Abreu et al. CANCER RESEARCH
- Overview of CDK9 as a target in cancer research
- (2016) Fatima Morales et al. CELL CYCLE
- EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
- (2016) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Neuroprotective Mechanisms Mediated by CDK5 Inhibition
- (2016) Gohar Mushtaq et al. CURRENT PHARMACEUTICAL DESIGN
- The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy
- (2016) Leslie J. Crofford et al. Expert Review of Clinical Immunology
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- The Effect of Conformational Flexibility on Binding Free Energy Estimation between Kinases and Their Inhibitors
- (2016) Mitsugu Araki et al. Journal of Chemical Information and Modeling
- Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity
- (2016) Shailesh Dudhgaonkar et al. JOURNAL OF IMMUNOLOGY
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy
- (2016) Yogesh A. Sonawane et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions
- (2016) Meining Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay
- (2016) Benjamin Merget et al. JOURNAL OF MEDICINAL CHEMISTRY
- Degradation of Akt using protein-catalyzed capture agents
- (2016) Ryan K. Henning et al. JOURNAL OF PEPTIDE SCIENCE
- Metabolically Labile Fumarate Esters Impart Kinetic Selectivity to Irreversible Inhibitors
- (2016) Balyn W. Zaro et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview
- (2016) Peter M. Fischer MEDICINAL RESEARCH REVIEWS
- Proteome-wide covalent ligand discovery in native biological systems
- (2016) Keriann M. Backus et al. NATURE
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
- (2016) Georg Petzold et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Identifying the functional contribution of the defatty-acylase activity of SIRT6
- (2016) Xiaoyu Zhang et al. Nature Chemical Biology
- Dynamic undocking and the quasi-bound state as tools for drug discovery
- (2016) Sergio Ruiz-Carmona et al. Nature Chemistry
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Screening out irrelevant cell-based models of disease
- (2016) Peter Horvath et al. NATURE REVIEWS DRUG DISCOVERY
- Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
- (2016) C Yang et al. ONCOGENE
- Activated PI3Kδ syndrome type 2: Two patients, a novel mutation, and review of the literature
- (2016) Peter Olbrich et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds
- (2016) Gregory J. Crowther et al. PLoS One
- ERK5 kinase activity is dispensable for cellular immune response and proliferation
- (2016) Emme C. K. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
- (2016) Catherine A. Evans et al. ACS Medicinal Chemistry Letters
- Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors
- (2016) Fleur M. Ferguson et al. ACS Medicinal Chemistry Letters
- Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR
- (2016) Timothy P. Heffron et al. ACS Medicinal Chemistry Letters
- Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign
- (2016) Nello Mainolfi et al. ACS Medicinal Chemistry Letters
- Selective inhibition of the kinase DYRK1A by targeting its folding process
- (2016) Isao Kii et al. Nature Communications
- CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
- (2016) Shawn F. Johnson et al. Cell Reports
- PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia
- (2015) Helois Radford et al. ACTA NEUROPATHOLOGICA
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
- (2015) Shahram Eisa-Beygi et al. ANTIVIRAL RESEARCH
- Quantifying the Entropy of Binding for Water Molecules in Protein Cavities by Computing Correlations
- (2015) David J. Huggins BIOPHYSICAL JOURNAL
- MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
- (2015) L. Beke et al. BIOSCIENCE REPORTS
- Abstract 2698: Combination strategies to target super enhancer transcriptional activity by CDK9 and BRD4 inhibition in acute myeloid leukemia
- (2015) Brigham L. Bahr et al. CANCER RESEARCH
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
- (2015) Alan Serrels et al. CELL
- Activity-Based Protein Profiling: Recent Advances in Probe Development and Applications
- (2015) Pengyu Yang et al. CHEMBIOCHEM
- Identification and Characterization of an Irreversible Inhibitor of CDK2
- (2015) Elizabeth Anscombe et al. CHEMISTRY & BIOLOGY
- Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
- (2015) C. Gebhardt et al. CLINICAL CANCER RESEARCH
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration
- (2015) Erik L. Meredith et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials
- (2015) Mario Fiore et al. JOURNAL OF MEDICINAL CHEMISTRY
- AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
- (2015) Samuel H. Myers et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12)
- (2015) Snahel Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling
- (2015) Guillaume Médard et al. JOURNAL OF PROTEOME RESEARCH
- Characterization of Human Cyclin-Dependent Kinase 12 (CDK12) and CDK13 Complexes in C-Terminal Domain Phosphorylation, Gene Transcription, and RNA Processing
- (2015) Kaiwei Liang et al. MOLECULAR AND CELLULAR BIOLOGY
- Chromatin-wide Profiling of DYRK1A Reveals a Role as a Gene-Specific RNA Polymerase II CTD Kinase
- (2015) Chiara Di Vona et al. MOLECULAR CELL
- Mediator kinase inhibition further activates super-enhancer-associated genes in AML
- (2015) Henry E. Pelish et al. NATURE
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease
- (2015) Trevor Dale et al. Nature Chemical Biology
- Prolonged and tunable residence time using reversible covalent kinase inhibitors
- (2015) J Michael Bradshaw et al. Nature Chemical Biology
- The ins and outs of selective kinase inhibitor development
- (2015) Susanne Müller et al. Nature Chemical Biology
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Translational value of mouse models in oncology drug development
- (2015) Stephen E Gould et al. NATURE MEDICINE
- Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
- (2015) Friedrich B M Reinhard et al. NATURE METHODS
- Kinase inhibitors and monoclonal antibodies in oncology: clinical implications
- (2015) Helen Gharwan et al. Nature Reviews Clinical Oncology
- Tuning kinase inhibitor residence time
- (2015) Megan Cully NATURE REVIEWS DRUG DISCOVERY
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- KLIFS: a structural kinase-ligand interaction database
- (2015) Albert J. Kooistra et al. NUCLEIC ACIDS RESEARCH
- GPCRdb: an information system for G protein-coupled receptors
- (2015) Vignir Isberg et al. NUCLEIC ACIDS RESEARCH
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Sulfonyl fluorides as privileged warheads in chemical biology
- (2015) Arjun Narayanan et al. Chemical Science
- Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
- (2015) William T. McElroy et al. ACS Medicinal Chemistry Letters
- Future Therapies of Wet Age-Related Macular Degeneration
- (2015) Makoto Ishikawa et al. Journal of Ophthalmology
- Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies
- (2015) Peter B. Alexander et al. Frontiers of Medicine
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System
- (2014) Dennis L. Buckley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
- (2014) Micah J. Niphakis et al. Annual Review of Biochemistry
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
- (2014) Camilla L. Christensen et al. CANCER CELL
- The basal transcription machinery as a target for cancer therapy
- (2014) Claudia Villicaña et al. Cancer Cell International
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Allosteric Inhibition of the IRE1α RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress
- (2014) Rajarshi Ghosh et al. CELL
- Chemical Interrogation of the Malaria Kinome
- (2014) Emily R. Derbyshire et al. CHEMBIOCHEM
- Redox-based probes as tools to monitor oxidized protein tyrosine phosphatases in living cells
- (2014) Francisco J. Garcia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Binding Free-Energy Calculation Is a Powerful Tool for Drug Optimization: Calculation and Measurement of Binding Free Energy for 7-Azaindole Derivatives to Glycogen Synthase Kinase-3β
- (2014) Kunihiro Kitamura et al. Journal of Chemical Information and Modeling
- Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
- (2014) S. B. Berger et al. JOURNAL OF IMMUNOLOGY
- Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models
- (2014) Snahel Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
- (2014) J. Wollenhaupt et al. JOURNAL OF RHEUMATOLOGY
- Design of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and Computational Analysis
- (2014) Shyam Krishnan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models
- (2014) T. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Pharmacological targeting of the pseudokinase Her3
- (2014) Ting Xie et al. Nature Chemical Biology
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- Covalent docking of large libraries for the discovery of chemical probes
- (2014) Nir London et al. Nature Chemical Biology
- A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
- (2014) Bryan R Lanning et al. Nature Chemical Biology
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical -propeller domain
- (2014) M. W. Richards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tracking cancer drugs in living cells by thermal profiling of the proteome
- (2014) M. M. Savitski et al. SCIENCE
- Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
- (2014) C. Marcela Diaz-Montero et al. SEMINARS IN ONCOLOGY
- New Frontiers in Kinases: Special Issue
- (2014) Maurizio Botta ACS Medicinal Chemistry Letters
- EML4-ALK Fusions: Propelling Cancer but Creating Exploitable Chaperone Dependence
- (2014) P. Workman et al. Cancer Discovery
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Kinase Drug Discovery – What’s Next in the Field?
- (2013) Philip Cohen et al. ACS Chemical Biology
- Animal models of CNS disorders
- (2013) Paul McGonigle BIOCHEMICAL PHARMACOLOGY
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
- (2013) Garrett W. Rhyasen et al. CANCER CELL
- Epidermal Growth Factor Receptor-Containing Exosomes Induce Tumor-Specific Regulatory T Cells
- (2013) Shao-hong Huang et al. CANCER INVESTIGATION
- Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition
- (2013) R. Katayama et al. CANCER RESEARCH
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- The CDK-activating kinase Cdk7
- (2013) Miriam Merzel Schachter et al. CELL CYCLE
- RNA Polymerase II Transcription Elongation Control
- (2013) Jiannan Guo et al. CHEMICAL REVIEWS
- PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models
- (2013) David G. Winkler et al. CHEMISTRY & BIOLOGY
- Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
- (2013) Qingsong Liu et al. CHEMISTRY & BIOLOGY
- Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
- (2013) H. Patterson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET--Letter
- (2013) L. Rimassa et al. CLINICAL CANCER RESEARCH
- Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones
- (2013) Xianming Deng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
- (2013) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- X-ray Crystal Structure of ERK5 (MAPK7) in Complex with a Specific Inhibitor
- (2013) Jonathan M. Elkins et al. JOURNAL OF MEDICINAL CHEMISTRY
- Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
- (2013) Rand M. Miller et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
- (2013) J. Hines et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Explaining why Gleevec is a specific and potent inhibitor of Abl kinase
- (2013) Y.-L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
- (2013) P. A. Schwartz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Death of a Titan
- (2013) M. Sudol et al. Science Signaling
- Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
- (2013) J. A. Moreno et al. Science Translational Medicine
- Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
- (2013) Jim Sang et al. Cancer Discovery
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
- (2013) Eva Maria Putz et al. Cell Reports
- Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
- (2013) Jan A. Burger Current Hematologic Malignancy Reports
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Chemistry-based functional proteomics for drug target deconvolution
- (2012) Kui Wang et al. Expert Review of Proteomics
- Plasmodiumkinases as targets for new-generation antimalarials
- (2012) Isabelle S Lucet et al. Future Medicinal Chemistry
- Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors
- (2012) Xingyu Lin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- (2012) Jeffrey M. Axten et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration
- (2012) Teresa Diago et al. MAYO CLINIC PROCEEDINGS
- Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
- (2012) Iana M Serafimova et al. Nature Chemical Biology
- Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair
- (2012) Xue Zhang et al. NATURE GENETICS
- AXL and acquired resistance to EGFR inhibitors
- (2012) Sophie Postel-Vinay et al. NATURE GENETICS
- Drug repositioning for Alzheimer's disease
- (2012) Anne Corbett et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanisms of Age-Related Macular Degeneration
- (2012) Jayakrishna Ambati et al. NEURON
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine kinase 1 in viral infections
- (2012) Jillian M. Carr et al. REVIEWS IN MEDICAL VIROLOGY
- Redox-Based Probes for Protein Tyrosine Phosphatases
- (2011) Stephen E. Leonard et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
- (2011) Kenji Takeuchi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
- (2011) Matthew P. Patricelli et al. CHEMISTRY & BIOLOGY
- High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors
- (2011) Chandrasekhar V. Miduturu et al. CHEMISTRY & BIOLOGY
- New Frontiers in Chemical Biology: Enabling Drug Discovery. Edited by Mark E. Bunnage.
- (2011) Joshua Kritzer ChemMedChem
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Role of LRRK2 kinase dysfunction in Parkinson disease
- (2011) Azad Kumar et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
- (2011) J. B. Stokes et al. MOLECULAR CANCER THERAPEUTICS
- IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation
- (2011) J K Cheong et al. ONCOGENE
- Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
- (2011) R. Katayama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Isoform-specific regulation of Akt by PDGF-induced reactive oxygen species
- (2011) R. Wani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1
- (2011) Xianming Deng et al. ACS Medicinal Chemistry Letters
- Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene
- (2010) Z. Chen et al. CANCER RESEARCH
- Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters
- (2010) Daniel D. Robinson et al. ChemMedChem
- Signaling cell death from the endoplasmic reticulum stress response
- (2010) Gordon C Shore et al. CURRENT OPINION IN CELL BIOLOGY
- The (un)targeted cancer kinome
- (2010) Oleg Fedorov et al. Nature Chemical Biology
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
- (2009) Elisa Greggio et al. ASN Neuro
- Neutralization of Vascular Endothelial Growth Factor Antiangiogenic Isoforms Is More Effective Than Treatment with Proangiogenic Isoforms in Stimulating Vascular Development and Follicle Progression in the Perinatal Rat Ovary1
- (2009) Robin A. Artac et al. BIOLOGY OF REPRODUCTION
- IRE1α Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates
- (2009) Dan Han et al. CELL
- Targeting protein kinases for the development of anti-inflammatory drugs
- (2009) Philip Cohen CURRENT OPINION IN CELL BIOLOGY
- Protein kinases as antibacterial targets
- (2009) Mark Schreiber et al. CURRENT OPINION IN CELL BIOLOGY
- Vinyl sulfone: a versatile function for simple bioconjugation and immobilization
- (2009) Julia Morales-Sanfrutos et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
- (2008) Frances Rena Bahjat et al. ARTHRITIS AND RHEUMATISM
- Imatinib resistance in CML
- (2008) Gisella Volpe et al. CANCER LETTERS
- Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding
- (2008) Robert Abel et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- High-throughput kinase profiling as a platform for drug discovery
- (2008) David M. Goldstein et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started